Hepatocellular adenomas: the expanding epidemiology

2021 ◽  
Vol 79 (1) ◽  
pp. 20-22
Author(s):  
Elizabeth M Brunt ◽  
Christine Sempoux ◽  
Paulette Bioulac‐Sage
JHEP Reports ◽  
2021 ◽  
pp. 100326
Author(s):  
Sophie Chopinet ◽  
François Cauchy ◽  
Christian Hobeika ◽  
Aurélie Beaufrère ◽  
Nicolas Poté ◽  
...  

2011 ◽  
Vol 35 (2) ◽  
pp. 159-166 ◽  
Author(s):  
Alampady Shanbhogue ◽  
Shetal N. Shah ◽  
Atif Zaheer ◽  
Srinivasa R. Prasad ◽  
Naoki Takahashi ◽  
...  

2009 ◽  
Vol 29 (1) ◽  
pp. 142-142 ◽  
Author(s):  
Paulette Bioulac-Sage ◽  
Herv Laumonier ◽  
Antonio Sa Cunha ◽  
Charles Balabaud

1992 ◽  
Vol 13 (9) ◽  
pp. 1541-1547 ◽  
Author(s):  
Jang Ja-June ◽  
Christopher M. Weghorst ◽  
John R. Henneman ◽  
Deborah E. Devor ◽  
Jerrold M. Ward

2021 ◽  
Vol 84 (3) ◽  
Author(s):  
G Moors ◽  
H Poels ◽  
V Vandecaveye ◽  
T Roskams ◽  
C Verslype

Hepatocellular adenoma (HCA) is an uncommon benign liver neoplasm usually solitary and identified incidentally on imaging. We report a case of a 50-year old female who was diagnosed with multiple hepatic adenomas of the inflammatory subtype. After discontinuation of oral contraception a decrease of both the number and size of the liver lesions was seen on magnetic resonance imaging (MRI) without the need of further intervention. The major challenge in the clinical management of patients with multiple HCAs resides in the risk assessment for future complications. In the case of multiple HCAs subtype seemed to be more relevant than the actual number of lesions. Because little is known about the natural evolution in patients with multiple HCAs, we performed a review of the current literature with focus on the different subtypes and their clinical relevance.


2020 ◽  
Vol 16 (12) ◽  
pp. 2117-2124
Author(s):  
Janindu Goonawardena ◽  
Chathri Ratnayake ◽  
King Tung Cheung ◽  
Adrian Fox

Sign in / Sign up

Export Citation Format

Share Document